Search

Prestige Consumer Healthcare

Slēgts

SektorsVeselības aprūpe

48.99 0.95

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

48.29

Max

50.29

Galvenie mērījumi

By Trading Economics

Ienākumi

7.2M

54M

Pārdošana

-1.8M

282M

P/E

Sektora vidējais

12.54

62.58

EPS

1.23

Peļņas marža

19.149

Darbinieki

890

EBITDA

4.5M

85M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+46.85% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 6. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-8.7M

2.4B

Iepriekšējā atvēršanas cena

48.04

Iepriekšējā slēgšanas cena

48.99

Ziņu noskaņojums

By Acuity

50%

50%

145 / 340 Rangs Healthcare

Prestige Consumer Healthcare Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 21. jūl. 15:41 UTC

Prestige Consumer Healthcare Inc shares are lower today, diverging from broader market strength as no specific news was identified to explain the decline.

2026. g. 20. jūl. 19:52 UTC

Prestige Consumer Healthcare Inc. is trading higher today, recovering from earlier lows. The stock remains near the upper end of its one-month range.

Salīdzinājums

Cenas izmaiņa

Prestige Consumer Healthcare Prognoze

Cenas mērķis

By TipRanks

46.85% augšup

Prognoze 12 mēnešiem

Vidējais 72 USD  46.85%

Augstākais 72 USD

Zemākais 72 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Prestige Consumer Healthcare — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

2

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

145 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat